Nexplanon Removal: Subcutaneous vs. Topical Lidocaine
Status:
Recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard
route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure
and time to removal.
Phase:
Phase 4
Details
Lead Sponsor:
Augusta University
Treatments:
Lidocaine Lidocaine, Prilocaine Drug Combination Prilocaine